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Abstract
Attention-deficit/hyperactivity disorder (ADHD) and depression commonly co-occur. Identifying children with ADHD at 
risk for later depression may allow early intervention and prevention. Irritability is one possible mechanism linking these 
two disorders. It is common in ADHD and associated with later depression in the general population. Cross-sectional studies 
suggest an association between irritability and depression in ADHD, but longitudinal research is limited. This study followed 
up a clinical ADHD sample longitudinally to examine: (1) the association between childhood irritability and later depression 
symptoms, and (2) whether irritability persistence is important in this association. At baseline, parents (n = 696) completed 
semi-structured interviews about their child (mean age = 10.9), providing information on child psychopathology, including 
irritability. A subsample (n = 249) was followed up after a mean of 5.4 years. Parent-completed Mood and Feelings Question-
naires provided information on depressive symptoms at follow-up. Parent-rated structured diagnostic interviews provided 
information on ADHD diagnosis and irritability at follow-up. Regression analyses examined associations between (i) baseline 
irritability and depression symptoms at follow-up, and (ii) persistent (vs. remitted) irritability and depression symptoms at 
follow-up. Analyses controlled for age, gender, depression symptoms, anxiety, ADHD symptoms, and ADHD medication 
at baseline. Baseline irritability was associated with depression symptoms at follow-up, but the association attenuated after 
controlling for anxiety and ADHD symptoms. Persistent irritability was associated with depression symptoms at follow-up, 
after including all covariates. Children with ADHD with persistent irritability are at elevated risk of developing depression 
symptoms. They may be a target for early intervention and prevention of depression.
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Introduction
Attention-deficit/hyperactivity disorder (ADHD) is a com-
mon, impairing neurodevelopmental disorder characterised 
by inattention, hyperactivity and impulsivity. Comorbidity 
is common, with more than 50% experiencing at least one 
other psychiatric disorder [1, 2]. Major depressive disorder 
(MDD) has been observed to occur more frequently in young 
people with ADHD than in those without [3–5], and levels 
of depression symptoms are higher across young adulthood 
in those with a history of childhood ADHD than in those 
without the disorder [6]. A meta-analysis found rates of 
MDD to be on average more than five times higher in those 
with ADHD than in those without [7].
This is important, as when depression co-occurs with 
ADHD, outcomes are worse than for either disorder alone. 
There is increased psychosocial impairment [8] and elevated 
risk for psychiatric hospital admission and suicidality [3]. 
In addition, as ADHD precedes the onset of depression [9], 
identifying those at risk provides an opportunity for early 
intervention and prevention.
Children with ADHD who are also irritable may be 
an important at-risk group for future depression. That is 
because population-based studies have consistently found 
irritability to be associated longitudinally with depres-
sion [10]. Irritability is a propensity to react with anger, 
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grouchiness or tantrums disproportionate to the situation 
[11]. When severe, irritability is impairing and is a com-
mon reason for referral to child psychiatry services [12]. It 
is particularly common in those with ADHD [13] and thus 
a possible mechanism that explains the high rates of depres-
sion in this group.
There has been little research into the longitudinal asso-
ciation between irritability and depression in those with 
ADHD. Although findings from the general population sug-
gest an association, these cannot automatically be extrapo-
lated to young people with ADHD. Firstly, it is not clear 
whether the irritability observed frequently in ADHD is the 
same as the irritability measured in the general population. 
Secondly, it is possible that gender may impact on the asso-
ciation between irritability and depression, and children with 
ADHD are predominantly male.
To date, two cross-sectional clinical ADHD samples have 
examined the association between irritability and depres-
sion, finding that irritability symptoms and the DSM-5 diag-
nosis of disruptive mood dysregulation disorder (DMDD), 
characterised by severe temper outbursts and persistent 
irritability, were associated with depression symptoms [14, 
15]. Longitudinally, the association between irritability and 
depression in a clinical ADHD sample is yet to be examined. 
Seymour et al. [16] did utilise a population sample, finding 
evidence that emotion regulation (a broader construct than 
irritability) mediates the relationship between ADHD symp-
toms and later depression symptoms. However, longitudinal 
investigation in a clinical ADHD sample is needed.
It is also relevant to consider whether irritability persis-
tence is important in the relationship between irritability 
and depression. Understanding whether it is persistent rather 
than remitting irritability that confers the greatest risk of 
depression would allow more precise targeting of preventive 
interventions. Pagliaccio et al. [17] found that, in a sample 
enriched for preschool depression, those with consistently 
elevated irritability trajectories across childhood were more 
likely to develop depression than those whose levels of irri-
tability started high but decreased over time. Wiggins et al. 
[18] also derived irritability trajectories across childhood 
(age 3–9 years), finding that internalising symptoms gener-
ally mirrored the patterns of the irritability trajectories (chil-
dren in a high, steady irritability trajectory or high, increas-
ing irritability trajectory had higher internalising symptoms 
by age 9 years than those with initially high but decreasing 
irritability). However, the impact of persistent irritability 
on risk for depression in children with ADHD has not been 
examined.
The aims of this study were to utilise an ADHD patient 
sample that was longitudinally assessed to: (1) examine the 
association between childhood irritability and adolescent 
depression symptoms, and (2) examine whether irritability 
persistence (vs. remittance) is important in this association.
Methods
Sample
The sample was made up of children who previously 
took part in the Study of ADHD, Genes and Environment 
(SAGE), at Cardiff University, UK. SAGE is a study of 
696 children aged 6–18 years (mean 10.9 years, SD = 2.99) 
who were recruited through psychiatry and paediatric clin-
ics between 2007 and 2011 [19]. All had a clinical diag-
nosis of ADHD and met DSM-IV or DSM-III-R research 
diagnostic criteria for ADHD. 84% were male and had a 
mean IQ of 83. All were of British Caucasian origin and 
living with at least one biological parent at the time of 
the study. Children were excluded if they had any major 
comorbid neurological disorder, psychosis, Tourette’s syn-
drome, autism or genetic syndrome.
A subsample of these participants aged ≤ 12 years at 
the time of initial data collection (mean age = 9.2 years, 
SD = 1.95), and whose family had consented to be con-
tacted for future research, was invited to take part in a 
follow-up study. The age criteria for inclusion (≤ 12 years 
at the time of initial data collection) were chosen to limit 
the prevalence of depression in the children at baseline. 
Follow-up was on average 5.4 years after initial participa-
tion (range 2–9 years, SD = 1.42). A total of 434 eligible 
participants were sent follow-up postal questionnaires 
between 2013 and 2016. 249 families returned completed 
questionnaires. Therefore, follow-up data were available 
for 57% of the eligible sample. Of those completing ques-
tionnaires, 124 also completed structured diagnostic inter-
views at follow-up. Figure 1 provides a flowchart detailing 
the numbers of participants taking part at each stage of the 
study. Ethical approval for this study was obtained from 
the Wales Multi-Centre Research Ethics committee. Par-
ents provided written informed consent and children gave 
written assent.
Measures
Baseline assessment (time 1)
Child psychopathology The parent-completed Child and 
Adolescent Psychiatric Assessment (CAPA) was used to 
measure baseline psychopathology in the child. The CAPA 
is a semi-structured diagnostic interview that involves inter-
viewers asking about symptoms of a range of psychiatric 
disorders present in the last 3 months [20]. The parent-com-
pleted CAPA was used to ascertain the presence of DSM-5 
psychiatric disorders including ADHD, major depressive 
disorder (MDD) and common childhood anxiety disorders 
(generalised anxiety disorder and separation anxiety dis-
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order). Symptom counts for MDD and ADHD were also 
derived based on the information provided in the CAPA. 
For symptoms to be endorsed on the CAPA they must be 
uncontrollable and interfere with at least two activities. All 
interviewers were trained to a high level of reliability. All 
interviews were recorded, and interviewers were supervised 
weekly by an experienced child and adolescent psychiatrist 
(AT).
Irritability: The CAPA was also used to assess baseline 
irritability. Irritability was defined both as a continuous 
score and a categorical diagnosis. The irritable score was 
calculated using three items from the oppositional defiant 
disorder (ODD) section of the CAPA, previously defined 
as making up an irritable dimension of ODD [21]. The 
items were “temper tantrums”, “touchy/easily annoyed” 
and “angry or resentful”. A total score of 0–3 was gener-
ated based on the presence or absence of these items. A 
categorical DSM-5 diagnosis of disruptive mood dysregu-
lation disorder (DMDD) was derived using items from the 
depression and ODD sections of the CAPA (described in 
Supplementary Material Table S1). We focused on DMDD 
diagnosis rather than ODD diagnosis as we were interested 
specifically in the association between irritability (rather 
than non-irritable ODD symptoms) and depression given 
previous findings [21–23].
Other measures Demographic information was recorded on 
parent-completed questionnaires at baseline. Child ADHD 
medication status was recorded using the parent-completed 
CAPA. Parents were asked whether or not their child takes 
Fig. 1  Flowchart showing 
numbers completing follow-up 
questionnaires and interviews
MFQ = Mood and Feelings Questionnaire, DAWBA = Development and Well-Being Assessment
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stimulant medication. All children completed the WISC-IV 
[24], providing a full-scale IQ.
Follow‑up assessment (time 2)
Child psychopathology: questionnaire data Depression 
symptoms: The parent-completed Mood and Feelings 
Questionnaire (MFQ) [25] was the primary measure used 
to measure depression symptoms at follow-up. The parent-
completed MFQ is a widely used depression screening 
instrument [26]. It is made up of 34 items, each rated as 0 
(not true), 1 (sometimes true) and 2 (true). Item scores were 
used to derive a total score, with a possible range of 0–68. A 
score of ≥ 21 on the parent-rated MFQ is an accepted cutoff 
when screening for possible depression [26] and was used to 
generate a binary MFQ outcome measure.
The child self-rated Mood and Feelings Questionnaire 
(MFQ) was also completed at follow-up on a smaller sample 
of participants (n = 169). The child self-rated MFQ is also 
widely used as a depression screening instrument [26] and 
is made up of 33 items (same items as the parent report, 
except “s/he wasn’t as happy as usual, even when s/he was 
praised or rewarded” is not included). It has a possible score 
range of 0–66.
Previous findings have suggested that young people with 
ADHD may under-report their own depression symptoms 
[27] which is why parent-reported depression was the pri-
mary outcome.
Child psychopathology: interview data The parent-com-
pleted Development and Well-Being Assessment (DAWBA) 
was used to measure child psychopathology at follow-up. 
The DAWBA is a structured interview covering common 
emotional, behavioural and hyperactivity disorders [28]. 
For each diagnostic category, computerised DAWBA algo-
rithms can be used to generate probability bands, ranging 
from a probability of having the relevant diagnosis of less 
than 0.1% to > 70%. The two highest probability bands have 
been described as equivalent to clinician-rated diagnosis 
[29]. These were used to establish the presence of DSM-5 
ADHD and MDD at follow-up. ADHD persistence was 
defined as presence of ADHD diagnosis at follow-up (as all 
of the sample had ADHD at baseline).
Irritability: Irritability at follow-up was also assessed 
using the DAWBA. A continuous score was generated using 
the same three items from the ODD section that were used to 
make the irritability score from the CAPA at baseline. They 
included “temper outbursts”, “easily annoyed” and “angry 
and resentful”. If the item was rated as being present “rarely 
or never” or “at least once per week”, then a score of 0 was 
assigned for that item. If it was rated as being present “most 
days” or “every day” then a score of 1 was assigned, provid-
ing a possible total score of 0–3. Irritability persistence was 
defined as an irritable score of ≥ 1 on the CAPA at baseline 
and ≥ 1 at follow-up on the DAWBA. A categorical diagno-
sis of DMDD was derived based on the symptoms reported 
in the DMDD section of the DAWBA (described in Sup-
plementary Material Table S1).
Analyses
Analyses were carried out using Stata version 14.
The baseline (time 1) characteristics and rates of psycho-
pathology for those who took part at each stage of the study 
were described, allowing comparison of responders and non-
responders at follow-up. Follow-up (time 2) characteristics 
and rates of psychopathology were described for those who 
completed follow-up questionnaires/interviews.
Association between irritability at baseline and later 
depression symptoms
The mean irritability score and percentage meeting criteria 
for DMDD diagnosis at baseline were established. Total par-
ent-rated MFQ scores and total child self-rated MFQ scores 
at follow-up were calculated. Where > 3 MFQ items (> 10%) 
were missing for an individual, the total score was counted 
as missing. Where ≤ 3 (< 10%) MFQ items were missing, a 
mean score of the completed items was imputed.
Linear regression was carried out to examine the associa-
tion between childhood irritability (baseline irritability score 
and DMDD diagnosis) and adolescent depression symptoms 
(follow-up parent-rated MFQ total). Due to the small num-
bers of participants who met diagnostic criteria for major 
depressive disorder on the DAWBA at follow-up (n = 6), it 
was not possible to examine the association between irrita-
bility and major depressive disorder diagnosis. Instead, a 
binary MFQ measure, based on being above or below the 
clinical cut point of ≥ 21 on the parent-rated MFQ, was used 
as an outcome. Regression analyses were run unadjusted, 
then controlling for child age, gender and baseline depres-
sion symptoms. Further covariates were assessed as sensitiv-
ity analyses (see below).
Persistent vs. remitted irritability
The percentage of the sample with persistent irritability was 
established. Linear regression was used to examine whether 
persistent vs remitted irritability was associated with total 
parent-rated MFQ score at follow-up, as well as examin-
ing the association between persistent vs remitted irritabil-
ity and the binary MFQ outcome. Analyses were run, first 
unadjusted, then controlling for child age, gender and base-
line depression symptoms. Further covariates were again 
assessed in sensitivity analyses (see below).
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Sensitivity analyses
Sensitivity analyses were conducted by (i) controlling for 
DSM-5 diagnosis of anxiety disorder (as anxiety commonly 
co-occurs with irritability and is associated with depression), 
ADHD symptoms and medication status at baseline (in addi-
tion to age, gender and baseline depression symptoms), (ii) 
removing the irritable item (he/she felt grumpy and irritable 
with his/her parents) from the parent-rated MFQ at follow-
up, (iii) examining whether any association between persis-
tent irritability and depressive symptoms was explained by 
persistent ADHD and (iv) using child self-rated MFQ total 
score to measure depression symptoms at follow-up.
Results
Sample characteristics
The baseline characteristics of participants who took part at 
each stage of the study are described in Table 1. Those who 
took part in follow-up were younger than those who were 
eligible but did not take part (9.0 vs 9.5 years, t(432) = 2.45, 
p = 0.01). However, there were no significant differences 
between responders and non-responders in terms of gender, 
IQ, parental income, ADHD medication or baseline child 
psychopathology (Supplementary Table S2). Sample char-
acteristics and rates of psychopathology at follow-up are 
reported in Table 2.
Descriptives
Irritability was a common symptom: at baseline (n = 696), 
the mean CAPA irritability symptom score was 2.19 (range 
0–3, SD = 1.0), with 91% of the sample reporting at least 
one irritable symptom. A total of 31% of the sample met 
diagnostic criteria for DMDD. At follow-up (n = 124), the 
mean DAWBA irritability symptom score was 1.46 (range 
0–3, SD = 1.3), with 64% of the sample reporting at least 
one irritable symptom, and 23% meeting diagnostic criteria 
for DMDD.
Depression symptoms at follow-up (n = 249) were also 
common: the mean total parent-rated MFQ score was 24.4 
(range 0–68, SD = 15.4), with 54.3% of the sample scor-
ing above the clinical cut point of ≥ 21 for parent-rated 
depression.
Irritability at baseline and depression symptoms 
at follow‑up (questionnaire sample)
Baseline irritability scores and DMDD diagnosis at base-
line were both associated with total parent-rated MFQ score 
at follow-up, controlling for child age, gender and baseline 
depression (irritability score: unstandardised B = 2.20, 95% 
CI 0.16, 4.28, standardised beta = 0.14, p = 0.035; DMDD: 
unstandardised B = 4.53, 95% CI = 0.53, 8.52, standardised 
beta = 0.15, p = 0.027) (Table 3: model 2, and Table 4: model 
2). However, using the MFQ binary measure as an outcome, 
Table 1  Baseline characteristics of (i) those taking part at baseline, (ii) those invited to follow-up, (iii) those completing follow-up question-
naires and (iv) those completing follow-up interviews
ADHD attention-deficit/hyperactivity disorder, DMDD disruptive mood dysregulation disorder, MDD major depressive disorder, Anxiety disor-
der includes generalised anxiety disorder or separation anxiety disorder, DMDD anxiety disorder and MDD diagnoses made using the CAPA, 
based on DSM-5 diagnostic criteria
a Number available for each variable ranged from 565 to 696
b Number available for each variable ranged from 364 to 434
c Number available for each variable ranged from 214 to 249
d Number available for each variable ranged from 109 to 124
(i) SAGE sample (n = 696)a (ii) Invited to follow-up 
(n = 434)b
(iii) Follow-up: ques-
tionnaire (n = 249)c
(iv) Follow-up: interview 
(n = 124)d
Gender,  % male (n) 84% (583) 82% (358) 82% (204) 80% (99)
Age, in years (range, SD) 10.9 (6–18, SD = 2.99) 9.2 (6–12, SD = 1.95) 9.0 (6–12, SD = 1.90) 8.5 (6–12, SD = 1.80)
IQ (range, SD) 83 (41–119, SD 13.4) 84 (46–119, SD = 12.4) 85 (50–119, SD = 12.5) 84 (58–118, SD = 12.0)
Income,  % < £20,000/year 
(n)
63% (358) 66% (239) 62% (133) 68% (74)
ADHD medication,  % (n) 80.6% (554) 77.3% (333) 77.9% (194) 79.0% (98)
Irritability score, mean 
(range, SD)
2.19 (0–3, SD = 1.0) 2.24 (0–3, SD = 0.95) 2.22 (0–3, SD = 0.94) 2.38 (0–3, SD = 0.79)
DMDD diagnosis,  % (n) 31% (207) 37.2% (152) 39.2% (93) 45.8% (55)
Anxiety disorder  % (n) 6.1% (40) 7.3% (30) 7.9% (19) 10.7% (13)
MDD diagnosis,  % (n) 1.9% (13) 1.4% (6) 1.6% (4) 0.8% (1)
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associations were only present for unadjusted models (see 
Supplementary Tables S3 and S4).
Persistent irritability and depression symptoms 
at follow‑up (interview sample)
A total of 63% (71/112) of those with an irritability score 
of ≥ 1 at baseline continued to have an irritability score 
of ≥ 1 at follow-up. 37% (19/51) of those who had DMDD at 
baseline continued to have DMDD at follow-up. Those with 
persistent irritability (score of ≥ 1 at baseline and follow-up) 
had higher mean parent-rated MFQ total scores at follow-up 
compared to those with remitted irritability (27.8 vs 17.1, 
t = − 3.8, p < 0.001). Persistent irritability (vs remitted irri-
tability) was associated with total parent-rated MFQ score at 
follow-up, controlling for age, gender and baseline depres-
sion symptoms (unstandardised B = 11.79, 95% CI = 6.28, 
17.30, standardised beta = 0.38, p < 0.001) (Table 5: model 
2). Using the MFQ binary measure as an outcome, asso-
ciations were consistent (OR 6.35, 95% CI 2.41, 16.73, 
p < 0.001) (see Supplementary Table S5).
Table 2  Characteristics of 
respondents at follow-up
ADHD attention-deficit/hyperactivity disorder, DMDD disruptive mood dysregulation disorder, MDD 
major depressive disorder, Anxiety disorder generalised anxiety disorder or separation anxiety disorder
a Number available for each variable ranged from 181 to 249
b Number available for each variable ranged from 113 to 124
Follow-up: questionnaires 
(n = 249)a
Follow-up: interviews (n = 124)b
Gender,  % male (n) 82% (204) 81% (99)
Age, in years (range, SD) 14.4 (8–19, SD = 2.38) 14.7 (11–20, SD = 2.10)
ADHD medication,  % (n) 69.6% (126) 69.8% (81)
MFQ total score (range, SD) 24.4 (0–68, SD = 15.4) 23.7 (0–68, SD = 15.13)
ADHD diagnosis,  % (n) – 66.7% (82)
Irritability score (range, SD) – 1.46 (0–3, SD = 1.29)
DMDD diagnosis,  % (n) – 22.6% (26)
MDD diagnosis,  % (n) – 4.9% (6)
Anxiety disorder,  % (n) – 22.8% (25)
Table 3  Association between irritability score at baseline and parent-rated total MFQ score at follow-up
N for analysis = 232
MFQ Mood and Feelings Questionnaire, ADHD attention-deficit/hyperactivity disorder, T1 at time 1, T2 at time 2, B unstandardised B coef-
ficient (B is the unit increase in MFQ score for every unit increase in irritable score), Beta standardised beta coefficient (Beta is the increase in 
standard deviations of MFQ score for every standard deviation increase in irritable score)
Outcome: MFQ total (T2)
B (95% CI) Beta (standard-
ised)
p value
Model 1: irritable score (T1): unadjusted 3.28 (1.25, 5.32) 0.21 0.002
Model 2: irritable score (T1): controlling for baseline age, gender, depression symptoms 2.20 (0.16, 4.25) 0.14 0.035
Model 3: irritable score (T1): controlling for baseline age, gender, depression symptoms, 
ADHD medication
2.22 (0.16, 4.28) 0.14 0.035
Model 4: irritable score (T1): controlling for baseline age, gender, depression symptoms 
and anxiety
1.82 (− 0.24, 3.87) 0.11 0.082
Model 5: irritable score (T1): controlling for baseline age, gender, depression symptoms 
and ADHD symptoms
1.72 (− 0.39, 3.83) 0.11 0.110
Model 6: irritable score (T1): controlling for baseline age, gender, depression symptoms, 
ADHD medication, anxiety and ADHD symptoms
1.38 (− 0.76, 3.51) 0.09 0.206
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Sensitivity analyses
Controlling for additional covariates
Sensitivity analyses found that associations for baseline 
irritability symptoms and depression, as well as baseline 
DMDD and depression attenuated when including addi-
tional covariates (no longer reaching statistical significance 
when including anxiety disorder and ADHD symptoms at 
baseline) (Table 3: models 4–6 and Table 4: models 4–6). 
However, the association was robust for persistent irritability 
after all covariates were added (Table 5: model 6).
Removing overlapping item
After removing the irritability item from the MFQ at follow-
up, the association between irritable score at baseline and 
parent-rated MFQ total, controlling for age, gender and base-
line depression symptoms was slightly weaker (unstandard-
ised B = 2.0, 95% CI − 0.02, 4.01, standardised beta = 0.13, 
p = 0.052). The association between DMDD at baseline 
and parent-rated MFQ total at follow-up remained similar 
(unstandardised B = 4.28, 95% CI 0.35, 8.21, standardised 
beta = 0.14, p = 0.033), as did the association between per-
sistent irritability and depression symptoms (unstandardised 
Table 4  Association between DMDD at baseline and parent-rated total MFQ score at follow-up
N for analysis = 224
MFQ Mood and Feelings Questionnaire, DMDD disruptive mood dysregulation disorder, ADHD attention-deficit/hyperactivity disorder, T1 at 
time 1, T2 at time 2, B unstandardised B coefficient (B is the difference in MFQ score at follow-up in those with DMDD compared to those 
without DMDD), Beta standardised beta coefficient (Beta is the standard deviation unit difference in MFQ score between those with DMDD and 
those without DMDD)
Outcome: MFQ total (T2)
B (95% CI) Beta (standard-
ised)
p value
Model 1: DMDD (T1): unadjusted 6.52 (2.50, 10.53) 0.21 0.002
Model 2: DMDD (T1): controlling for baseline age, gender, depression symptoms 4.53 (0.53, 8.52) 0.15 0.027
Model 3: DMDD (T1): controlling for baseline age, gender, depression symptoms, 
ADHD medication
4.52 (0.51, 8.53) 0.15 0.027
Model 4: DMDD (T1): controlling for baseline age, gender, depression symptoms and 
anxiety
3.97 (− 0.019, 7.96) 0.13 0.051
Model 5: DMDD (T1): controlling for baseline age, gender, depression symptoms and 
ADHD symptoms
3.81 (− 0.25, 7.87) 0.12 0.066
Model 6: DMDD (T1): controlling for baseline age, gender, depression symptoms, 
ADHD medication, anxiety and ADHD symptoms
3.32 (− 0.74, 7.38) 0.11 0.108
Table 5  Association between persistent irritability and parent-rated total MFQ score at follow-up
N for analysis = 107
MFQ Mood and Feelings Questionnaire, ADHD attention-deficit/hyperactivity disorder, T1 at time 1, T2 at time 2, B unstandardised B coeffi-
cient (B is the difference in MFQ score at follow-up in those with persistent irritability compared to those with remitted irritability), Beta stand-
ardised beta coefficient (Beta is the standard deviation unit difference in MFQ score between those with persistent irritability and those without 
persistent irritability)
Outcome: MFQ total (T2)
B (95% CI) Beta (standard-
ised)
p value
Model 1: persistent irritability: unadjusted 10.49 (4.86, 16.12) 0.34 <0.001
Model 2: persistent irritability: controlling for baseline age, gender, depression symptoms 11.79 (6.28, 17.30) 0.38 <0.001
Model 3: persistent irritability: controlling for baseline age, gender, depression symp-
toms, ADHD medication
12.06 (6.54, 17.59) 0.39 <0.001
Model 4: persistent irritability: controlling for baseline age, gender, depression symptoms 
and anxiety
11.23 (5.78, 16.70) 0.36 <0.001
Model 5: persistent irritability: controlling for baseline age, gender, depression symptoms 
and ADHD symptoms
11.24 (5.68, 16.80) 0.36 <0.001
Model 6: persistent irritability: controlling for baseline age, gender, depression symp-
toms, ADHD medication, anxiety and ADHD symptoms
10.81 (5.30, 16.33) 0.35 <0.001
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B = 11.44, 95% CI = 6.06, 16.81, standardised beta = 0.38, 
p < 0.001).
Persistent ADHD
Irritability was found to persist alongside ADHD. Of those 
who had persistent irritability (n = 71), 75% also had persis-
tent ADHD (n = 53) (OR 2.3, 95% CI 1.02, 5.21, p = 0.045). 
However, persistent irritability continued to be associated 
with depression symptoms at follow-up after controlling for 
persistent ADHD (in the sample that completed follow-up 
interviews) (unstandardised B = 10.85, 95% CI 5.41, 16.29, 
standardised beta = 0.35, p < 0.001).
Child self‑rated MFQ as an outcome
The associations between irritability score and child self-
rated depression symptoms and between persistent irrita-
bility and child self-rated depression symptoms were simi-
lar to the associations seen using parent-rated depression 
symptoms as an outcome (Tables S6 and S8, Supplemen-
tary Material). However, baseline DMDD diagnosis was not 
associated with child self-reported MFQ score at follow-up 
(Table S7).
Discussion
The main aims of this study were to utilise a longitudinal, 
clinical ADHD sample to examine whether childhood irri-
tability is associated with later depression symptoms and 
establish whether persistent irritability accounts for this 
association.
Our results suggest that childhood irritability at baseline 
(whether defined as a continuous measure or categorical 
diagnosis of DMDD) is associated with adolescent depres-
sion symptoms at follow-up. These results support findings 
from the general population which have consistently found a 
longitudinal association between irritability and depression 
[10]. They also support cross-sectional findings suggesting 
that irritability is associated with depression symptoms in 
those with ADHD [14, 15] and findings from a longitudinal 
population-based sample suggesting that emotion regulation 
mediates the association between ADHD symptoms and 
depression symptoms [16]. However, in the current study, 
we no longer found strong evidence of an association when 
either baseline anxiety or baseline ADHD symptoms were 
included as covariates.
With regard to anxiety as a covariate, one possible expla-
nation is that the current study used the MFQ as a measure 
of depression symptoms at follow-up, rather than depression 
diagnosis. Although the MFQ is a widely used depression 
screening instrument [26], items do overlap with symptoms 
of anxiety, which may explain why anxiety is an important 
predictor of MFQ total score. It is also possible that the 
association between baseline irritability and later depres-
sion symptoms is explained by co-occurring anxiety disor-
der. Irritability is associated with anxiety [10], and anxiety 
(particularly, generalised anxiety disorder) is closely linked 
to depression [30]. Therefore, anxiety would be a feasible 
explanation for any association between irritability and 
depression. However, both irritability and anxiety have been 
observed to be important antecedents for adolescent depres-
sion in other populations, including those at high familial 
risk for depression [31].
Importantly, for those with persistent irritability, signifi-
cantly higher depression symptoms were observed in adoles-
cence, even after including childhood anxiety as a covariate. 
Similarly, whilst baseline ADHD symptoms impacted on the 
association between baseline irritability and later depression 
symptoms, the association between persistent irritability and 
depression symptoms at follow-up remained when including 
baseline or persistent ADHD symptoms as a covariate. This 
suggests that it is the persistence of irritability rather than 
ADHD symptom severity or ADHD persistence that might 
be important in contributing risk for depression here.
The association between persistent irritability and depres-
sion symptoms also remained when the irritability item was 
removed from the MFQ at follow-up, suggesting that the 
high parent-rated MFQ score in those with persistent irrita-
bility was not as a result of the irritable item on the MFQ. 
The finding was also consistent when total parent-rated 
MFQ score or an MFQ clinical cutoff of ≥ 21 was used as 
an outcome measure, and also when child self-rated MFQ 
score was used as the outcome measure. The association 
between persistent irritability and depression is supported by 
the evidence from studies examining irritability trajectories. 
These also show that those with persistently high irritability 
seem to have more depression and internalising symptoms 
than those who have high initial irritability that decreases 
over time [17, 18]. However, what was not clear from the 
present study is whether it is the persistence of irritability 
or the presence of irritability in adolescence (i.e. present at 
follow-up) that is particularly important for conferring risk 
for depression. Due to the majority of this sample having 
irritability at baseline, it was not possible to test this here.
Overall, these findings suggest irritability is important in 
the link between ADHD and depression symptoms, although 
it may be specifically persistent irritability that is important.
These findings are relevant for clinicians. They sug-
gest that, in those with a diagnosis of ADHD, irritability 
is important and should be identified and monitored. Those 
who continue to experience irritability into adolescence may 
be at particular risk for depression and may be the ones who 
should be considered as a target for intervention/prevention 
of depression.
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Limitations
It is important to consider a number of limitations in this 
study. Firstly, the size of the follow- up sample was relatively 
small, with only a subset of parents completing follow-up 
interviews. As a result of this, too few met criteria for a diag-
nosis of major depressive disorder at follow-up to use this as 
an outcome measure (although all 6 with MDD at follow-up 
met criteria for DMDD at baseline). The young age of the 
follow-up sample (mean= 14.4 years) may have contributed 
to this, with many not yet reaching the peak age of risk for 
onset of depression. Follow-up into early adulthood would 
be helpful in future studies.
Another limitation was that the interview measure used 
to assess irritability and ADHD at follow-up (DAWBA) 
differed from that used at baseline (CAPA). The DAWBA 
was used at follow-up as it is a briefer measure than the 
CAPA, and was more feasible to complete with the fami-
lies involved. However, this change in measure across the 
two time points meant that it was not possible to directly 
compare prevalence of disorders across time in this sample. 
Despite this, it is worth noting that when comparisons of 
DAWBA and CAPA were made [32], no significant differ-
ences in the rates of ADHD were found and the majority 
of those with a DAWBA diagnosis also received a CAPA 
diagnosis.
There are also limitations with regard to the generalisabil-
ity of the results. Firstly, it could be argued that this ADHD 
sample may not be representative due to the study exclusion 
criteria (any major comorbid neurological disorder, psycho-
sis, Tourette’s syndrome, autism or genetic syndrome). How-
ever, despite this, many of the disorders that often co-occur 
with ADHD were not exclusion criteria for this study, e.g. 
oppositional defiant disorder, conduct disorder, intellectual 
disability and specific learning disorders, and despite the 
exclusion of those with a clinical diagnosis of autism, the 
sample had high levels of autistic traits [33]. Therefore, we 
consider this sample to be fairly representative of children 
from South Wales, UK, who have a diagnosis of ADHD. It 
is also important to note that these results are relevant only 
to those with clinically ascertained ADHD. Even so, it could 
be argued that early intervention and prevention of depres-
sion may be most feasible for those who are already known 
to clinical services.
Conclusions
This study found that persistent irritability in those with 
ADHD is associated with depression symptoms in adoles-
cence. This suggests that chronically irritable children with 
ADHD may be a target group for early intervention and pre-
vention of depression, and that those who remain irritable 
over time should be monitored most carefully.
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